Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Royalty Pharma is a leading investor in medical innovation, headquartered in the US. The company acquires and finances vital medicines through long-term royalty and financing agreements. Through strategic partnerships, Royalty Pharma enables pharmaceutical companies to advance research and development, bringing life-changing therapies to patients globally.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Royalty Pharma is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Royalty Pharma last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 1.32 USD.
Across its last 5 earnings reports, Royalty Pharma stock moved by ±1.9% on average the following day. The largest reaction was +6.8% on 11/05/2025; 5 of 5 reactions were positive.
Royalty Pharma has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.